Signaling Pathways

Scientists Find Small Molecules That Directly Inhibit β‑Arrestins

The compounds bind an allosteric pocket to block arrestin-driven pathways without stopping G protein signaling and open new preclinical routes for pathway-specific GPCR drugs.